Vaccinia virus (ATCC® VR-2047)

Classification: Poxviridae, Orthopoxvirus  /  Product Format: frozen

Classification Poxviridae, Orthopoxvirus
Agent Vaccinia virus
Strain vP-13
Biosafety Level 2
Isolation
A HhaI fragment encoding HBsAg was cloned into vP-8 (ATCC VR-2053) by in vivo recombination. No expression of the insert has been detected.
Product Format frozen
Storage Conditions -70°C or colder
Comments
Recombinant vaccinia containing the Hhal hepatitis B fragment coding for HBV surface antigen.
A HhaI fragment encoding HBsAg was cloned into vP-8 (ATCC VR-2053) by in vivo recombination. No expression of the insert has been detected.
Effect on Host
Yes, in vitro effects: Cytopathic effects in tissue culture
CPE.
Effect on Host
Yes, in vitro effects: Cytopathic effects in tissue culture
CPE.
Name of Depositor E Paoletti
References

Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986

Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988

Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520

Hammon WM, et al. Isolation and characterization of prototype viruses ECHO-26, ECHO-27, Coxsackie B-6. Proc. Soc. Exp. Biol. Med. 103: 164-168, 1960. PubMed: 14399342